跳至主要内容
临床试验/NCT03307590
NCT03307590已完成2 期

Adding Dexmedetomidine to Caudal Bupivacaine for Analgesia in Supra - Umbilical Pediatric Surgeries: Would it Add More Analgesia

Cairo University1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2017年10月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
24
试验地点
1
主要终点
Pain relief

研究概览

简要总结

dexmedetomidine is an alpha 2 adrenergic receptor agonist that is given either systemically or combined to local anesthetics during regional blocks. Investigators studied the combination of dexmedetomedine/bupivacaine versus bupivacaine alone for caudal blockage in pediatric patients undergoing supra - umbilical surgeries.

详细描述

Dexmedetomidine was combined to bupivavaine and administered via caudal route to be compared to caudal bupivavaine alone for analgesia following upper trunk surgery

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
1 Year 至 6 Years(Child)
性别
All
接受健康志愿者

入选标准

  • supra - umbilical surgeries

排除标准

  • allergy to the drug or coagulopathy

研究组 & 干预措施

D group

Active Comparator

Dexmedetomidine with bupivacaine group Caudal dexmedetomidine 1.5 microgram/kg with bupivavaine (0.25%) 1.25 ml/kg were administered

干预措施: Dexmedetomidine (Drug)

B group

Active Comparator

Bupivacaine only group Caudal bupivavaine (0.25%) 1.25 ml/kg without dexmedetomidine was administered

干预措施: Bupivacaine (Drug)

结局指标

主要结局

Pain relief

时间窗: 6 months study

CHEOPS scale value

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Kareem

Anesthesiologist

Cairo University

研究点 (1)

Loading locations...

相似试验